Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barbieri, C. E.
Right arrow Articles by Pietenpol, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barbieri, C. E.
Right arrow Articles by Pietenpol, J. A.
[Cancer Research 66, 7589-7597, August 1, 2006]
© 2006 American Association for Cancer Research


Cell, Tumor, and Stem Cell Biology

Loss of p63 Leads to Increased Cell Migration and Up-regulation of Genes Involved in Invasion and Metastasis

Christopher E. Barbieri1,3, Luo Jia Tang1,3, Kimberly A. Brown2,3 and Jennifer A. Pietenpol1,3

1 Department of Biochemistry, Center in Molecular Toxicology; 2 Department of Cancer Biology; and 3 Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee

Requests for reprints: Jennifer A. Pietenpol, Department of Biochemistry, Vanderbilt University, 652 Preston Building, 23rd Avenue South at Pierce Avenue, Nashville, TN 37232. Phone: 615-936-1512; Fax: 615-936-1790; E-mail: j.pietenpol{at}vanderbilt.edu.

p63, a homologue of the tumor suppressor p53, is critical for the development and maintenance of squamous epithelia. p63 is specifically expressed in the basal layers of stratified epithelial tissues and is considered a specific marker for cells of this type. The role of p63 in tumorigenesis remains poorly defined. Numerous studies have highlighted the oncogenic potential of the predominant p63 isoform {Delta}Np63{alpha}; however, data suggest that other p63 proteins can act as tumor suppressors or alter the metastatic potential of tumors. {Delta}Np63{alpha} can act as a transcriptional repressor, but the link between the transcriptional functions of p63 and its biological role is still unclear. In this study, we used a loss-of-function approach to investigate the transcriptional programs controlled by p63. Disruption of p63 in squamous cell lines resulted in down-regulation of transcripts specifically expressed in squamous tissues and a significant alteration of keratinocyte differentiation. Interestingly, we found that disruption of p63 led to up-regulation of markers of nonepithelial tissues (mesenchyme and neural tissue) in both primary and immortalized squamous cells. Many of these up-regulated genes are associated with increased capacity for invasion and metastasis in tumors. Furthermore, loss of p63 expression was accompanied by a shift toward mesenchymal morphology and an increase in motility in primary keratinocytes and squamous cell lines. We conclude that loss of endogenous p63 expression results in up-regulation of genes associated with invasion and metastasis, and predisposes to a loss of epithelial and acquisition of mesenchymal characteristics. These findings have implications for the role of p63 in both development and tumorigenesis. (Cancer Res 2006; 66(15): 7589-97)




This article has been cited by other articles:


Home page
DevelopmentHome page
Y. Shimomura, M. Wajid, L. Shapiro, and A. M. Christiano
P-cadherin is a p63 target gene with a crucial role in the developing human limb bud and hair follicle
Development, February 15, 2008; 135(4): 743 - 753.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Higashikawa, S. Yoneda, K. Tobiume, M. Taki, H. Shigeishi, and N. Kamata
Snail-Induced Down-Regulation of {Delta}Np63{alpha} Acquires Invasive Phenotype of Human Squamous Cell Carcinoma
Cancer Res., October 1, 2007; 67(19): 9207 - 9213.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Teissier, Y. Ben Khalifa, M. Mori, P. Pautier, C. Desaintes, and F. Thierry
A New E6/P63 Pathway, Together with a Strong E7/E2F Mitotic Pathway, Modulates the Transcriptome in Cervical Cancer Cells
J. Virol., September 1, 2007; 81(17): 9368 - 9376.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Roman, A. Petre, A. Thepot, A. Hautefeuille, J.-Y. Scoazec, F. Mion, and P. Hainaut
Downregulation of p63 upon exposure to bile salts and acid in normal and cancer esophageal cells in culture
Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G45 - G53.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.